"Genesis Medical Center, East Rusholme Street provides comprehensive medical services including state-of-the-art operating rooms."

During the past decade, Genesis Medical Center - East Campus conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 49 clinical trials were completed, i.e. on average, 108.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 25 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Medical Center - East Campus" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Medical Center - East Campus" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Medical Center - East Campus" are "Breast Cancer" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Coronary Artery Disease" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Genesis Medical Center - East Campus" in a lesser frequency.

Most popular intervention types in "Genesis Medical Center - East Campus" are "Drug" (87 trials), "Other" (57 trials), "Biological" (33 trials), "Device" (15 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (20 trials), "Paclitaxel" (13 trials), "Bevacizumab" (10 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Medical Center - East Campus" are 96 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Medical Center - East Campus". undefined are not yet recruiting, 13 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Genesis Medical Center - East Campus, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Medical Center - East Campus, 1 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".

Genesis Medical Center - East Campus has several departments that took part in Clinical trials: "Genesis Regional Cancer Center at Genesis Medical Center" - 60 trials, "Genesis Cancer Care Institute" - 42 trials, "Genesis Cancer Center - Silvis" - 31 trials, "Genesis Heart Institute" - 2 trials